Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

I previously didn't think it was ready to do this for a few more months,...

We are 4 to 6 weeks away from the unblinded B-ABSSSI results. Worst case scenario is the 3 day, .6 mg/kg course will be the one with almost no counter indications. A huge improvement over all other approved drugs.

Leo's preliminary report hinted that one of the two single dose regimens would be the best results, something we now see restated in the 10K. This is an even better improvement over all other ABSSSI antibiotics.

I'm surprised that this next leg of buying and higher valuation started today instead of last week.